TP53 is known to be implicated in the early onset of various cancer types, including BCC, where the loss of heterozygosity (LOH) of p53, the protein encoded by TP53, seems to be mutually exclusive with PTCH1 [10,13]. The gene discussed is TP53; the disease is skin basal cell carcinoma.